[FORM 10-Q x September 30, 2010 For the quarterly period ended o For the transition period from ___________ to ___________. SinoCoking Coal and Coke Chemical Industries, Inc. (Exact name of issuer as specified in its charter) Florida (State or other jurisdiction of incorporation or organization) 65-0420146 (I.R.S. employer identification number) Kuanggong Road and Tiyu Road 10th Floor, Chengshi Xin Yong]
[Issuance of ADRs; Pre-Release (1) In its capacity as Depositary, the Depositary shall not lend Shares or ADSs; provided, however, that the Depositary may issue ADSs prior to the receipt of Shares (each such transaction a "Pre-Release"). The Depositary may receive ADSs in lieu of Shares to close out a Pre-Release (which ADSs will promptly be canceled by the Depositary]
[Registration No. 333-164027 Prospectus Supplement No. 1 (To prospectus dated February 19, 2010) CHINA XD PLASTICS COMPANY LIMITED 3,301,739 Shares of Common Stock This prospectus supplement, dated October 27, 2010, supplements the prospectus dated February 19, 2010 of China XD Plastics Company Limited, relating to the resale by selling shareholders of China XD Plastics Company Limited of up to 3,301,739]
[Registration No. 333-164027 Prospectus Supplement No. 1 (To prospectus dated February 19, 2010) CHINA XD PLASTICS COMPANY LIMITED 3,301,739 Shares of Common Stock This prospectus supplement, dated October 27, 2010, supplements the prospectus dated February 19, 2010 of China XD Plastics Company Limited, relating to the resale by selling shareholders of China XD Plastics Company Limited of up to 3,301,739]
[TABLE OF CONTENTS Page ABOUT THIS PROSPECTUS SUPPLEMENT ii SUMMARY S-1 RISK FACTORS S-10 S-13 USE OF PROCEEDS S-14 CAPITALIZATION S-15]
[TABLE OF CONTENTS Page ABOUT THIS PROSPECTUS SUPPLEMENT ii SUMMARY S-1 RISK FACTORS S-10 S-13 USE OF PROCEEDS S-14 CAPITALIZATION S-15]
[Prospectus Supplement 8,050,000 Ordinary Shares Chinard Bloodrporation Chinard Bloodrporation is offering 7,000,000 ordinary shares and certain of our shareholders (Selling Shareholders) are offering 1,050,000 ordinary shares. 10 Investing in our ordinary shares involves risks. Please read Risk Factors beginning on page S- PER SHARE TOTAL Public Offering Price]
[Prospectus Supplement 8,050,000 Ordinary Shares Chinard Bloodrporation Chinard Bloodrporation is offering 7,000,000 ordinary shares and certain of our shareholders (Selling Shareholders) are offering 1,050,000 ordinary shares. 10 Investing in our ordinary shares involves risks. Please read Risk Factors beginning on page S- PER SHARE TOTAL Public Offering Price]
[The information in this preliminary prospectus supplement is notmplete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, nor are they soliciting offers to buy these securities, in any jurisdiction where the offer orle is not permitted. SUBJECT TOMPLETION,TED NOVEMBER 4, 2010]
[TABLE OF CONTENTS PROSPECTUS SUMMARY 6 Overview 6 Business Overview of SGOCO 7 Recent Development 7 8 Corporate Information 8 Risks Affecting SGOCO 12 RISK FACTORS 12 Risks Related to Our Business and Industry 13 Risks Relating to the Company 17 Risks Related to Doing Business in China 20 Risks Relating to Our Securities 24 25 IDENTITY OF DIRECTORS, SENIOR]
